(Methemoglobinemia)
4,705 results
  • Acute nitrate/nitrite poisoning in cattle caused by ingestion of Tithoniatubaeformis. [Journal Article]
    Toxicon. 2026 Jun 11; 281:109191. [Online ahead of print]Micheloud JF, Aguirre LS, … Riet-Correa FT
  • An outbreak of acute mortality affecting 13% of a herd of 450 beef cattle is described in the province of Salta, Argentina. The incident occurred after the introduction of the herd into a paddock that had previously been used for cattle confinement. Approximately 8 h after being introduced into the paddock, the affected animals developed hyperacute clinical signs, including weakness, ataxia, tach…
  • When Fire and Ice Collide: A Rare Case of Idiopathic Angioedema with Dapsone-Induced Methemoglobinemia. [Journal Article]
    J Emerg Med. 2026 Jun 10; 87:83-86. [Online ahead of print]Siddiqua N, Panda BPD, … Jamshed NJE
  • Idiopathic angioedema is a potentially life-threatening cause of acute airway compromise, with reported mortality rates up to 30% when airway intervention is delayed. Methemoglobinemia, a dyshemoglobinemia that reduces hemoglobin's oxygen-carrying capacity, can be acquired from drugs such as dapsone and occurs in approximately 0.4-1% of exposed patients. The coexistence of these two entities is e…
  • Dapsone and schistocytes: Thrombotic microangiopathy or not? [Journal Article]
    PLoS One. 2026; 21(5):e0349570.Archambeaud A, Aumont C, … Bigot APlos
  • CONCLUSIONS: Dapsone appears to be associated with hemolytic anemia and the presence of schistocytes, suggesting mechanical intravascular haemolytic anaemia. Whether Dapsone-associated biological thrombotic microangiopathy can be associated with target organ damage requires further investigation.
  • Discordantly Low HbA1c in Patients Receiving Dapsone: Prevalence and Associations with Hemolysis and Methemoglobinemia. [Journal Article]
    Int J Endocrinol Metab. 2026 Jul 31; 24(3):e166723.Chandran T, Anwar Hussain M, … Thomas NIJ
  • CONCLUSIONS: A high prevalence of discordantly low HbA1c was observed among patients receiving dapsone therapy, highlighting an important clinical pitfall in the interpretation of HbA1c. While hemolysis and methemoglobinemia remain biologically plausible contributors, these findings should be considered hypothesis-generating. Clinicians should exercise caution when interpreting HbA1c in patients treated with dapsone and consider alternative glycemic markers such as fructosamine.